ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

アトロピン

Npc209773

HCID 174174
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
16175-85-2
標準SMILES
CN1[C@@H]2CC[C@H]1CC(OC(=O)C(CO)c1ccccc1)C2
InChIKey
RKUNBYITZUJHSG-SPUOUPEWSA-N
分子式
C17H23NO3
平均分子量
289.4 g/mol
単同位体質量
289.1677936

概要

Atropine is a racemate composed of equimolar concentrations of (S)- and (R)-atropine. It is obtained from deadly nightshade (Atropa belladonna) and other plants of the family Solanaceae. It has a role as an antidote to sarin poisoning, a oneirogen, a bronchodilator agent, an anti-arrhythmia drug, a muscarinic antagonist, a parasympatholytic, a mydriatic agent, an anaesthesia adjuvant and a plant metabolite. It contains a (S)-atropine and a (R)-atropine.

名称と識別子

優先名称
Npc209773
IUPAC
[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
現地名
アトロピン
英語名
Atropine
分子式
C17H23NO3
分子量
289.37

名称と別名

RefChem:1092872Npc209773ATROPINE51-55-8dl-HyoscyamineAtropenAtropinTropine tropatedl-TropyltropateAtropinolEyesulesIsopto-atropine
名称をさらに表示
アトロピンrac-(αR*)-α-(ヒドロキシメチル)ベンゼン酢酸(1β,5β)-8-メチル-8-アザビシクロ[3.2.1]オクタン-3α-イル(±)-ヒオスシアミンrac-(αR*)-α-(ヒドロキシメチル)ベンゼン酢酸(1R,5S)-8-メチル-8-アザビシクロ[3.2.1]オクタン-3α-イル(±)-トロピルトロパート(±)-ヒオスチアミンrac-(R*)-α-(ヒドロキシメチル)ベンゼン酢酸(1R,5S)-8-メチル-8-アザビシクロ[3.2.1]オクタン-3α-イル(±)-α-(ヒドロキシメチル)ベンゼン酢酸(1R,5S)-8-メチル-8-アザビシクロ[3.2.1]オクタン-3α-イルrac-(R*)-α-(ヒドロキシメチル)ベンゼン酢酸(1R,5S)-トロパン-3α-イルトロピン(±)-トロパートrac-(R*)-α-(ヒドロキシメチル)ベンゼン酢酸(1β,5β)-8-メチル-8-アザビシクロ[3.2.1]オクタン-3α-イルrac-(αR*)-α-ヒドロキシメチルベンゼン酢酸(1β,5β)-8-メチル-8-アザビシクロ[3.2.1]オクタ-3α-イルDL-トロピルトロパートDL-ヒオスシアミン(±)-アトロピン(±)-ヒヨスチアミンdl-ヒヨスチアミンd-hyoscyamineHSDB2199

物性

構造計算による物性

XLogP
1.8
極性表面積
49.8 Ų
水素結合供与体数
1
水素結合受容体数
4
回転可能結合数
5
重原子数
21
形式電荷
0
複雑度
353

実験および物理化学的性質

Solubility>43.4 [ug/mL] (The mean of the results at pH 7.4)
Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Dissociation Constants · 3 件

9.84

9.84

9.43

Collision Cross Section171.5 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

物理化学的性質

融点
115 · 115-118 °C
沸点
431.53 °C · 431.53°C (rough estimate)
比重(密度)
1.047 · 1.0470 (rough estimate)
屈折率
1.52 · 1.5200 (estimate)
闪点
2 ℃ · 2℃
貯蔵温度
-20 °C · -20°C
溶解性
2 O: · H2O: 2 mg/mL
外見
粉
酸解離定数(Pka)
9.7 · 9.7(at 21℃)
色
白い
水溶解度
1.6 g/L · 1.6g/L(18℃)
Merck
14 · 14,875

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

安全データ

F
8-10-23
wgk
3
tsca
TSCA listed
rtecs
CK0700000
ridadr
1544
毒性
LD50 orally in rats: 750 mg/kg (Cahen, Tvede)
hs_code
29399900
risk_code
26/28-36/37/38-20/21/22-36-11
hazard_code
T+,Xn,F
safety_code
25-45-36-26-36/37-16
hazard_class
6.1
packing_group
III
Hazard Classifications
Acute Tox. 2 InhalationAcute Tox. 2 Oral
ストレージクラス
6.1A - Combustible acute toxic Cat. 1 and 2very toxic hazardous materials
有毒物質データの
51-55-8(Hazardous Substances Data)

化学と産業

薬理情報

ATC CodeA03BA01
Protein BindingThe protein binding of atropine ranges from 14% to 44%, and is saturable between 2 and 20 μg/mL.
Pharmacodynamics · 1 件

Atropine is an antimuscarinic agent that antagonizes the effects of acetylcholine. In small doses, atropine slows heart rate, and tachycardia develops due to paralysis of vagal control. Compared to [scopolamine], atropine has a more potent and prolonged effect on the heart, intestine and bronchial muscle, but a weaker effect on the iris, ciliary body and certain secretory glands. Atropine leads to increased respiratory rate and depth of respiration, possibly due to the drug-induced bronchiolar dilatation rather than its mild effect on vagal excitation. At an adequate dose, atropine abolishes different types of reflex vagal cardiac slowing or asystole. Atropine can be used to prevent or abolish bradycardia or asystole induced by the injection of choline esters, anticholinesterase agents or other parasympathomimetic drugs, and cardiac arrest produced by stimulation of the vagus. When vagal activity is an etiologic factor, atropine may also lessen the degree of partial heart block. In clinical doses, atropine counteracts the peripheral dilatation and abrupt decrease in blood pressure produced by choline esters. However, when given by itself, atropine does not exert a striking or uniform effect on blood vessels or blood pressure. The use of topical atropine in the eye induces mydriasis by inhibiting the contraction of the circular pupillary sphincter muscle normally stimulated by acetylcholine. This results in the contraction of the countering radial pupillary dilator muscle and pupil dilation. The use of atropine may precipitate acute glaucoma and convert partial organic pyloric stenosis into complete obstruction. Atropine may also lead to complete urinary retention in patients with prostatic hypertrophy and cause the thickening of bronchial secretions and formation of viscid plugs in patients with chronic lung disease.

Mechanism of Action · 1 件

Atropine binds to and inhibits muscarinic acetylcholine receptors, competitively blocking the effects of acetylcholine and other choline esters. It acts as a reversible non-specific antagonist of muscarinic receptors, showing affinity for the M1, M2, M3, M4 and M5 receptor subtypes. Atropine antagonizes the effects of acetylcholine on tissues innervated by postganglionic cholinergic nerves, such as smooth muscle, cardiac tissue, exocrine glands and the central nervous system. Also, it acts in less innervated smooth muscle that responds to endogenous acetylcholine. The actions of atropine can be overcome by increasing the concentration of acetylcholine at receptor sites (for instance, the use of anticholinesterase agents that inhibit the hydrolysis of acetylcholine).

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
Atropisol
Troyl tropateAtropinaAtropin-flexiolen(+,-)-Tropyl tropateAtropin [German]Atropina [Italian]hyoscyamine(+/-)-Atropine

データベース識別子

CAS
16175-85-2、51-55-8
PubChem CID
174174
DTXSID
DTXSID4020113
ChEMBL
CHEMBL254656、CHEMBL475124
ChEBI
CHEBI:16684
UNII
7C0697DR9I、HA7DL7YA9K
Nikkaji
J1.385.555B、J1.566.306E
BRN
91260 · 91260
主な用途
医薬品
InChI
1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15+,16
InChIKey
RKUNBYITZUJHSG-SPUOUPEWSA-N
SMILES
CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c3ccccc3
CAS データベース
51 · 51-55-8(CAS DataBase Reference)
NISTの化学物質情報
Atropine(51-55-8)
EPAの化学物質情報
Atropine (51-55-8)

化学的性質

化学的特性Atropine, also known as daturine, C17H23NO3, white, crystalline substance, optically inactive, but usually contains levorotatory hyoscyamine. Compound is soluble in alcohol, ether, chloroform, and glycerol; slightly soluble in water.

Biological Half-Life · 1 件

Following intravenous and intramuscular doses of atropine, half-life values range from approximately 2 to 4 hours. In geriatric patients (65-75 years old), intravenous atropine has a longer half-life (10 hours). Also, the half-life of atropine is slightly shorter (approximately 20 minutes) in females than in males. In healthy volunteers given 30 µL of atropine sulfate by topical ocular administration, the half-life of atropine was approximately 2.5 hours.

Metabolism/Metabolites · 1 件

Atropine is mainly metabolized by enzymatic hydrolysis in the liver. The major metabolites of atropine are noratropine, atropin-n-oxide, tropine, and tropic acid. The metabolism of atropine is inhibited by organophosphate pesticides.[L42815,​​L42835]

Absorption, Distribution and Excretion · 4 件

Intravenous atropine follows a non-linear pharmacokinetic model at doses between 0.5 and 4 mg. After intramuscular administration, atropine is rapidly absorbed. In adults given 1.67 mg of atropine intramuscularly, the Cmax was 9.6 ng/mL and the Tmax went from 3 to 60 minutes. In healthy subjects given 30 µL of atropine ophthalmic solution, the Cmax and Tmax were 288 pg/mL and 28 minutes, respectively. Atropine is well absorbed in the gastrointestinal tract and rapidly delivered to systemic circulation. When administered intramuscularly, atropine has a bioavailability of 50%. The AUC0-INF and Cmax of atropine are higher in females than males (15%).

Approximately 13 to 50% of atropine is excreted unchanged in the urine. In healthy volunteers given intravenous atropine, 29% of tropine was excreted in urine, along with 15% of an unidentified metabolite.

Atropine is distributed throughout the body. Following intravenous administration, the total apparent volume of distribution of atropine ranged between 1.0 and 1.7 L/kg.

Following intravenous administration, the total clearance of atropine ranged between 5.9 and 6.8 mL/min/kg. Exercise, before and after intramuscular administration, decreases the clearance of atropine.

用途と製造

Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan
応用分野 · 5 件

解説ナス科のベラドンナ,ヒヨスなどに含まれるヒヨスチアミン(l体)がラセミ体化したアルカロイド.C17H23NO3.神経毒の一種.神経系のアセチルコリン受容体に結合することにより,気管支や消化器官の緊張緩和,心拍数や血圧の上昇を引き起こす.大量投与では呼吸麻痺や幻覚・錯乱などが現れる.

用途医薬 (マッシュルーム中毒の解毒剤、コリンエステラーゼ阻害剤に対する解毒剤)

説明Atropine is considered to be the most effective antidote for both OP and CB intoxication. By effectively competing with acetylcholine for the same cellular receptors, it prevents overstimulation of the autonomous parasympathetic system. Most importantly, it helps prevent asphixia, the main cause of death. In human subjects, it is customary to constantly infuse atropine in order to maintain optimal concentration throughout recovery from the “cholinergic crisis.” In wildlife rehabilitation, this is impractical and subjects need to be repeatedly injected with atropine.

使用Atropine is used in medicine and is an antidote for cholinesteraseinhibiting compounds, such as organophosphorus insecticides and certain nerve gases. Atropine is commonly offered as the sulfate. Atropine is used in connection with the treatment of disturbances of cardiac rhythm and conductance, notably in the therapy of sinus bradycardia and sick sinus syndrome. Atropine is also used in some cases of heart block. In particularly high doses, atropine may induce ventricular tachycardia in an ischemic myocardium. Atropine is frequently one of several components in brand name prescription drugs.

一般的な説明Atropine is the tropine ester of racemictropic acid and is optically inactive. It possibly occurs naturallyin various Solanaceae, although some claim, with justification,that whatever atropine is isolated from naturalsources results from racemization of (-)-hyoscyamine duringthe isolation process. Conventional methods of alkaloidisolation are used to obtain a crude mixture of atropine andhyoscyamine from the plant material. This crude mixture isracemized to atropine by refluxing in chloroform or by treatmentwith cold dilute alkali. Because the racemizationprocess makes atropine, an official limit is set on thehyoscyamine content by restricting atropine to a maximumlevorotation under specified conditions.Atropine occurs in the form of optically inactive, white,odorless crystals possessing a bitter taste. It is not very solublein water (1:460, 1:90 at 80°C) but is more soluble inalcohol (1:2, 1:1.2 at 60°C). It is soluble in glycerin (1:27),in chloroform (1:1), and in ether (1:25). Saturated aqueoussolutions are alkaline in reaction (pH 9.5). The free baseis useful when nonaqueous solutions are to be made, such asin oily vehicles and ointment bases. Atropine has a plasmahalf-life of about 2 to 3 hours. It is metabolized in the liverto several products, including tropic acid and tropine.

調製方法

Atropine is prepared by extraction from Datura stramonium, or synthesized. The compound is toxic and allergenic.

純化方法Atropine crystallises from acetone or hot water, and sublimes at ~ 100o/high vacuum. [Beilstein 21/1 V 235.]

上流・下流製品情報

上流原料

クロロホルム

下流製品

硫酸アトロピン一水和物rac-(R*)-α-(ヒドロキシメチル)ベンゼン酢酸(1β,5β)-8-(1-メチルエチル)-8-アザビシクロ[3.2.1]オクタン-3α-イル硝酸メチルアトロピン

サプライヤー100 社

武汉英诺医药科技有限公司+86-027-59232304 15387063101 · [email protected]
盐城通铭生物科技有限公司15195160625 · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
广州隽沐生物科技股份有限公司020-36607679; 13502246435 · [email protected]
成都健腾生物技术有限公司028-85159085 18080455027 · [email protected]
咸宁深蓝生物医药研发有限公司18171815831 · [email protected]
云南西力生物技术股份有限公司0871-65217109 · [email protected]
南京望知星医药科技有限公司18569809817 · [email protected]
湖北科乐精细化工有限公司027-59101668 19945030958 · [email protected]
广州隽唐科技有限公司020-36607679 13502246435 · [email protected]
广州蓝宁生物科技有限公司15813355568 · [email protected]
LGM Pharma1-(800)-881-8210 · [email protected]
Syntechem Co.,Ltd[email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
Cangzhou Wanyou New Material Technology Co.,Ltd18631714998 · [email protected]
西安泽邦生物科技有限公司[email protected]
成都普思生物科技股份有限公司028-85370565-229 18080489829 · [email protected]
MedBio脉铂医药021-69568360 18916172912 · [email protected]
MedChemexpress LLC021-58955995 · [email protected]
医恩医疗系统研发(上海)有限公司021-58958002 18930822973 · [email protected]
上海瀚香生物科技有限公司177-54423994 17754423994 · [email protected]
湖北恩星生物科技有限公司16621771607 · [email protected]
佛山宝诺生物科技有限公司0757-85921206 18520245316 · [email protected]
云南西力生物技术股份有限公司0871-65217109 · [email protected]
上海毕楷科技有限公司18516304666 · [email protected]
ChemeGen 中国18818260767 · [email protected]
上海耐士化工科技有限公司400-188-0725 +86 21 34310725 13611771617
斯百全化学(上海)有限公司021-021-021-67601398-809-809-809 15221380277 · [email protected]
深圳菲斯生物科技有限公司0755-83725681-603
TCI AMERICA800-4238616 · [email protected]
TOKYO CHEMICAL INDUSTRY CO., LTD.03-36680489 · [email protected]
TCI Europe320-37350700 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
Clearsynth Labs Limited+91-22-26355700 · [email protected]
广州爱纯医药科技有限公司020-39119399 18927568969 · [email protected]
武汉鹏胤药业有限公司13163333255 · [email protected]
南京世洲生物科技有限公司13675144456 · [email protected]
美岚实业(上海)有限公司021-58958189 · [email protected]
雷丁试剂0510-85629785 18013409632 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
上海麦克林生化科技股份有限公司15221275939 15221275939 · [email protected]
杭州杰恒化工有限公司0571-87396432 · [email protected]
上海永叶生物科技有限公司86-021-61559134 15921386130 · [email protected]
武汉贝乐叶生物医药科技有限公司18086118078 · [email protected]
池州凯隆进出口贸易有限公司[email protected]
Sigma-Aldrich西格玛奥德里奇(上海)贸易有限公司021-61415566 800-8193336 · [email protected]
深圳振强药物研发有限公司+86-0755-66853366 +86-13670046396 · [email protected]
石家庄通洋进出口有限公司[email protected]
上海语纯生物科技有限公司021-021-52273538 17321241593 · [email protected]
武汉天植生物技术有限公司18607101326 15172504745 · [email protected]

補足説明

定義An alkaloid that is the 3(s)-endo isomer of atropine.